Full-Time
Electrical Designer/Drafter
ABEC
501-1,000 employees
Integrated bioprocessing equipment and services.
No salary listed
Wilson, NC, USA
In Person
On-site at the Wilson, North Carolina facility; travel is required as needed.
Associate's
 Electrical Engineering (1) |
|---|
Get referred to ABEC
See people who can refer or advise you
- A two-year technical degree or equivalent experience is required.
- Two or more years of industrial electrical design experience are required.
- Experience with control systems, instrumentation, and motor controls is required.
- Experience with AutoCAD Electrical is required.
- Ability to read electrical drawings and P&IDs is required.
- Familiarity with drafting standards, electrical codes, and bills of material is required.
- Ability to manage multiple priorities independently and as part of a team is required.
- Design electrical schematics, wiring diagrams, panel layouts, and conduit schedules.
- Create panel assembly drawings and bills of material.
- Apply I/O lists, P&IDs, customer specifications, and applicable codes.
- Support PLC, DCS, VFD, and motor-control designs.
- Work with engineers, manufacturing, project teams, and field service.
- Verify installations and support equipment startups.
- Maintain design documentation and ERP data.
- Identify continuous-improvement opportunities.
- Travel as required.
- Experience with Rockwell, Siemens, or DeltaV PLC/DCS hardware.
- Experience with Syteline, SAP, or another ERP system.
- Experience with EPLAN Electric P8 or Pro Panel.
- Panel assembly, wiring, or commissioning experience.
- Experience in biopharmaceutical, industrial equipment, or custom-machinery manufacturing.
ABEC provides integrated biopharmaceutical manufacturing solutions and services. It supports vaccine and antibody production with bioprocess engineering, equipment maintenance, troubleshooting, and repairs, plus design and build of complete bioprocess lines. It offers customized single-use disposable containers, especially Custom Single Run (CSR) products, leveraging 45+ years of design experience. Its goal is to help clients scale manufacturing faster and at lower costs through in-house engineering, global capacity, and long-term partnerships.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Bethlehem, Pennsylvania
Founded
1974
Get referred to ABEC
See people who can refer or advise you
Simplify's Take
What believers are saying
- ABEC’s ATB targets cell therapy, one of bioprocessing’s fastest-growing manufacturing segments.
- Wilson’s 2026 buildout expands disposable-container output for vaccines and therapeutic proteins.
- Process Sciences expansion on May 5, 2026 strengthens customer stickiness around process transfer.
What critics are saying
- ABEC settled part of the Good Meat dispute for $4.4 million in March 2025.
- Litigation exposed ABEC’s dependence on customer funding discipline and large custom-project payment timing.
- A failed cultivated-meat market leaves ABEC with stranded engineering capacity and underutilized bioreactor know-how.
What makes ABEC unique
- ABEC’s May 2026 Process Sciences expansion deepens bioprocess optimization and scale-up expertise.
- ATB launched March 31, 2025, combines closed automation with hollow-fiber cell expansion.
- Wilson, North Carolina plant adds ISO-7 single-use container capacity and 251 jobs.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Paid Holidays
Paid Vacation
Medical, dental and vision insurance
Company paid life insurance
401(k) Company Match
401(k) Retirement Plan
College tuition benefit program
Employee Referral Program
Growth & Insights and Company News
6 month growth
↑ 12%1 year growth
↑ 12%2 year growth
↑ 12%ABEC, a global leader in engineered solutions and services for biotechnology manufacturing, has introduced its Advanced Therapy Bioreactor (ATB(TM), a revolutionary platform focused on transforming cell expansion for Advanced Therapy Medicinal Products (ATMPs).
Eat Just and its cultivated meat subsidiary GOOD Meat have reached an agreement in principle to settle their legal dispute* with bioreactor supplier ABEC, according to court documents, although the matter has not yet reached a final resolution.In a letter to Judge Wendy Beetlestone dated February 6, attorneys for both parties explained that they “have engaged in serious settlement negotiations over the past few months and have reached an agreement in principle regarding the framework for a settlement agreement and the material terms.“However, due to the complex nature of the claims, defenses, and counterclaims,” they added, “the parties require additional time to draft a binding agreement.”In a court order filed on February 7, Judge Beetlestone agreed to their request for the court to appoint a magistrate judge as settlement master to facilitate a final resolution, but rejected their request for a 30-day stay on the litigation and all case deadlines.Neither party has responded to a request for comment from AgFunderNews.What is the case about?The legal dispute began in March 2023 when ABEC filed a lawsuit accusing GOOD Meat of breach of contract by failing to pay its bills on time.According to ABEC, GOOD Meat owed $62,649,231.79 for work ABEC had already completed. Eat Just, in turn, claimed that ABEC had breached the terms of their contract.ABEC, which had been working with GOOD Meat on pilot cultivated chicken facilities in California and Singapore, signed an agreement with the startup in August 2021. Under the seven-year deal, ABEC would design, manufacture, install and commission multiple 250,000-liter vessels— “the largest known bioreactors for avian and mammalian cell culture”—for a large-scale facility in the US.Given “financing hurdles,” by November 2022, Eat Just/GOOD Meat “recommended the evaluation of a phased approach, creating five 125,000-L bioreactors instead of four 250,000-L bioreactors,” and the two started corresponding over amendments to their agreement.By March 2023, ABEC said it had had no choice but to take legal action over unpaid bills. Eat Just/GOOD Meat responded by filing a series of counterclaims, arguing that the parties never formally ratified amendments to their original agreement, and that ABEC had simply proceeded as if they had.Speaking to AgFunderNews last year, Eat Just founder and CEO Josh Tetrick said he was “not attempting to raise money for a large-scale cultivated meat facility right now” and was instead focusing on process development at the firm’s plant in Alameda, California, and working on new cell lines he claimed would enable more efficient large-scale production.*The case is ABEC, Inc. v. Eat Just, Inc
Cultivated meat startup GOOD Meat has upped the ante in its increasingly ugly legal dispute with bioreactor specialist ABEC over alleged nonpayment of bills. GOOD has filed a series of counterclaims alleging that ABEC breached the terms of their contract and that GOOD Meat is in fact the wronged party. The litigation began in March 2023 when ABEC filed a lawsuit accusing GOOD Meat (a wholly owned subsidiary of Eat Just) of breach of contract by failing to pay its bills on time. ABEC, which had been working with GOOD Meat on pilot cultivated chicken facilities in California and Singapore, signed an agreement with the startup in August 2021. Under the seven-year deal, ABEC would design, manufacture, install and commission multiple 250,000-liter vessels— “the largest known bioreactors for avian and mammalian cell culture”—for a large-scale facility in the US with the capacity to produce up to 30 million pounds of meat
Eat Just—like Beyond Meat—is often seen as a proxy for the broader alternative protein space, regarded by some as a visionary foodtech pioneer attempting to disrupt two vast addressable markets (meat, eggs) and by other less charitable observers as a “house of cards built on one individual’s ability to separate people from their money.”. Regardless of where you sit on this spectrum, says one foodtech investor we spoke to this week, it would be “pretty catastrophic” for the category if either of these loss-making firms were to crash and burn, so a lot is riding on their performance in the coming months. So how should we view Eat Just, and can Tetrick—”one of the best capital-raisers in the business“— raise the funds to take cultivated meat from a loss-making novelty to a commercially viable alternative to animal agriculture?
Malcolm joins KPC from ABEC Inc, where he led the development of their European Services Business and contributed to their global capital project expansion.